CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 112,546,000	$ 144,454,000
Accounts receivable, net of allowance of $8,265 in 2022 and $5,668 in 2021	400,619,000	368,348,000
Inventories	367,823,000	269,030,000
Other current assets	220,489,000	173,823,000
Total current assets	1,101,477,000	955,655,000
Long-Term Assets:
Property and equipment, net	649,474,000	587,667,000
Operating lease right-of-use assets	118,618,000	105,101,000
Goodwill	361,795,000	359,345,000
Intangible assets, net	97,672,000	99,035,000
Other long-term assets	417,729,000	330,400,000
Total long-term assets	1,645,288,000	1,481,548,000
TOTAL ASSETS	2,746,765,000	2,437,203,000
Current Liabilities:
Accounts payable	110,221,000	116,140,000
Accrued liabilities	433,662,000	458,909,000
Credit facility	579,000,000	73,500,000
Current portion of long-term debt	74,982,000	74,996,000
Current portion of deferred revenue	37,938,000	40,034,000
Total current liabilities	1,235,803,000	763,579,000
Long-Term Liabilities:
Deferred income tax liabilities	8,150,000	8,935,000
Long-term debt, net of current portion	694,387,000	775,205,000
Long-term deferred revenue, net of current portion	30,862,000	41,174,000
Long-term operating lease liabilities	101,239,000	87,377,000
Other long-term liabilities	67,587,000	70,941,000
Total long-term liabilities	902,225,000	983,632,000
Total liabilities	2,138,028,000	1,747,211,000
Commitments and Contingencies (Note 16)
Stockholders’ Equity:
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 107,193 shares in 2022 and 106,878 shares in 2021; Outstanding: 82,894 shares in 2022 and 84,562 shares in 2021	10,719,000	10,688,000
Additional paid-in capital	1,463,215,000	1,377,320,000
Deferred stock units: Outstanding: 58 units in 2022 and 90 units in 2021	5,182,000	5,719,000
Retained earnings	3,599,529,000	2,920,440,000
Accumulated other comprehensive loss	(77,796,000)	(53,484,000)
Treasury stock, at cost: 24,299 shares in 2022 and 22,317 shares in 2021	(4,392,112,000)	(3,570,691,000)
Total IDEXX Laboratories, Inc. stockholders’ equity	608,737,000	689,992,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 2,746,765,000	$ 2,437,203,000